
Continuous Processing in Pharmaceutical Manufacturing
Description
Alles über E-Books | Antworten auf Fragen rund um E-Books, Kopierschutz und Dateiformate finden Sie in unserem Info- & Hilfebereich.
Recent advances in single-use technology as well as application guidelines for all types of biopharmaceutical products, from vaccines to antibodies, and from bacterial to insect to mammalian cells are covered. The efficiency, robustness, and quality control of continuous production processes for biopharmaceuticals are reviewed and compared to traditional batch processes for a range of different production systems.
More details
Other editions
Additional editions


Person
A chemistry graduate from Madras, India, Dr. Subramanian was awarded his doctorate, from the University of Glasgow, for work on natural products. His main research interests lie in the utilization of natural material separation processes and bioconversions.
Dr. Subramanian has written and edited a number of books and articles in the field of biotechnology. For the last 15 years, he has been organizing conferences promoting the integration and sharing of knowledge between academia and industry.
Content
Simulated moving bed, expanded adsorption and continuous ion exchange process in downstream processing
Continuous Flow Manufacturing in downstream biologics
Continuous and single-use technologies to establish a new downstream processing platform for monoclonal antibodies
Continuous perfusion processes for mammalian cell cultures
The Review of Flexible Production platforms for the future
BioSMB technology as an enabler for a fully continuous disposable biomanuafacturing platform
mAB continuous processing enabled by single use
Perfusion process design in a 2-D rocking single-use bioreactor
Multicolumn countercurrent gradient chromatography for the purification of Biopharmaceuticals
Opportunities and Challenges for the Implementation of Continuous Processes to Biomanufacturing
Implementation of CQA (Critical quality attributes) based approach for Development of Biosimilars
Optimization of Continuous Downstream Process in Biopharmaceutical Manufacturing
Automated single-use centrifugation solution for diverse biomanufacturing processes
Evaluating the economic and operational feasibility of continuous processes for monoclonal antibodies
The Potential Impact of Continuous Processing on the Practice and Economics of Biopharmaceutical Manufacturing
Very high cell density in perfusion of CHO cells by ATF, TFF, Wave bioreactor and/or CellTank technologies - Impact of cell density and applications
Advances in the application of perfusion technologies to Drosophila S2 insect cell culture
Single-use Systems Support Continuous Bioprocessing
1
Proteins Separation and Purification by Expanded Bed Adsorption and Simulated Moving Bed Technology
Ping Li, Pedro Ferreira Gomes, José M. Loureiro, and Alirio E. Rodrigues
1.1 Introduction
Proteins not only play an important role in biology, but also have large potential applications in pharmaceuticals and therapeutics, food processing, textiles and leather goods, detergents, and paper manufacturing. With the development of molecular biology technologies, various kinds of proteins can be prepared from upstream processes and from biological raw materials. However, there exist various proteins and contaminants in these source feedstocks, and the key issue is that proteins can be separated and purified efficiently from the source materials, in order to reduce the production cost of the high-purity protein. The development of techniques and methods for proteins separation and purification has been an essential prerequisite for many of the advancements made in biotechnology.
Most separation and purification protocols require more than one step to achieve the desired level of protein purity. Usually, a three-step separation and purification strategy is presented, which includes capture, intermediate separation and purification, and final polishing during a downstream protein separation and purification process. In the capture step the objectives are to isolate, concentrate, and stabilize the target proteins. During the intermediate separation and purification step the objectives are to remove most of the bulk impurities, such as other proteins and nucleic acids, endotoxins, and viruses. In the polishing step most impurities have already been removed except for trace amounts or closely related substances. The objective is to achieve final purity of protein.
In the capture step, as the primary recovery of proteins, the expanded bed adsorption (EBA) technology has been widely applied to capture proteins directly from crude unclarified source materials, such as, Escherichia coli homogenate, yeast, fermentation, mammalian cell culture, milk, and animal tissue extracts [1,2]. The expanded bed is designed in a way that the suspended adsorbent particles capture target protein molecules, while cells, cell debris, particulate matter, and contaminants pass through the column unhindered. After loading and washing, the bound proteins can be eluted by elution buffer and be concentrated in a small amount of elution solution, apart from the bulk impurities and contaminants in source materials. With specially designed adsorbents and columns, the adsorption behavior in expanded beds is comparable to that in fixed beds. Various applications of EBA technology have been reported from laboratory-scale to pilot-plant and large-scale production [1-9].
During the intermediate purification and final polishing steps, the techniques of the conventional elution chromatography have been applied successfully. A new challenge should be the application of simulated moving bed (SMB) to the separation and purification of proteins. SMB chromatography is a continuous process, which for preparative purposes can replace the discontinuous regime of elution chromatography. Furthermore, the countercurrent contact between fluid and solid phases used in SMB chromatography maximizes the mass transfer driving force, leading to a significant reduction in mobile and stationary phase consumption when compared with elution chromatography [10-14]. Examples of products that are considered for SMB separation and purification are therapeutic proteins, antibodies, nucleosides, and plasmid DNA [15-23].
When the binding capacities of proteins on adsorbent are close to each other, an isocratic SMB mode may be used to separate and purify the proteins, where the adsorbents have the same affinity capacity to proteins in all sections in SMB chromatography. However, usually the binding capacities of proteins are so different that we cannot separate them by the isocratic mode with a reasonable retention time. In conventional elution chromatography, a gradient mode should be used for the separation of proteins. It is most commonly applied in reversed-phase and ion exchange chromatography (IEC), by changing the concentration of the organic solvent and salt in a stepwise gradient or with a linear gradient, respectively. For SMB chromatography, only a stepwise gradient can be formed by introducing a solvent mixture with a lower strength at the feed inlet port compared with the solvent mixture introduced at the desorbent port; then the adsorbents have a lower binding capacity to proteins in sections I and II to improve the desorption, and have a stronger binding capacity in sections III and IV to increase adsorption in SMB chromatography. Some authors state that the solvent consumption by gradient mode can be decreased significantly when compared with isocratic SMB chromatography [17-19,24-29]. Moreover, when a given feed is applied to gradient SMB chromatography, the protein obtained from the extract stream can be enriched if protein has a medium or high solubility in the solution with the stronger solvent strength, while the raffinate protein is not diluted at all [24].
In this chapter, we shall describe the developments made at the Laboratory of Separation and Reaction Engineering (LSRE) for proteins separation and purification by expanded bed chromatography and salt gradient ion exchange simulated moving bed technology.
1.2 Protein Capture by Expanded Bed Technology
1.2.1 Adsorbent Materials
The design of a special adsorbent is a key factor to enhance the efficiency of expanded bed adsorption. The EBA process will be more effective for those adsorbents that have both high-density base matrix and salt-tolerant ligand. The high-density matrix means minimizing dilution arising from biomass or viscosity in feedstock and reducing dilution buffer consumption; the lack of sensitivity of the ligand to ionic strength and salt concentration means there is no need for dilution of feedstock [30-32].
"Homemade" adsorbents are commonly used for research purposes. Agarose and cellulose are the major components utilized on the tailoring of the adsorbents. Table 1.1 shows a list of such adsorbents.
Table 1.1 "Homemade" adsorbents.
Year Core Adsorbent Reference 1994 Crystalline quartz 6% Agarose [33] 1994 Perfluorocarbon Polyvinyl alcohol - perfluorodecalin [34] 1995 Crystalline quartz - Red H-E7B 6% Agarose [35] 1995 Perfluorocarbon Polyvinyl alcohol - perfluoropolymer [36] 1996 Crystalline quartz - Cibacron blue (3GA) 6% Agarose [37] 1997 Fluoride-modified porous zirconium oxide [38] 1999 Polyacrylamide gel Silica [39] 1999 Glass Agarose [40] 2000 Celbeadsa) Cellulose [41] 2000 Stainless steel Agarose [30] 2001 Celbeadsa) Cellulose [42] 2001 Nd-Fe-B alloy powder Agarose [43] 2002 Stainless steel 6% Agarose [44] 2002 Stainless steel 6% Agarose [45] 2002 Crystalline quartz 6% Agarose (Streamline DEAE) modified with a layer of polyacrylic acid (PAA) [46] 2002 Nd-Fe-B with Cibacron Blue 3GA (CB) 4% Agarose [47] 2002 Zirconia-silica (ZSA) 4% Agarose [9] ZSA - Cibracron Blue (CB) 4% Agarose 2003 Zirconia-silica (ZSA) Agarose [48] 2003 CB-6AS Cellulose [49] 2003 Titanium oxide Cellulose [50] 2004 Glass 4% Agarose [51] 2005 Titanium oxide Cellulose [52] 2005 Stainless steel powder Cellulose [53] 2006 Stainless steel powder Cellulose [54] 2007 Nickel powder Cellulose [55] 2007 Tungsten carbide Cellulose [56] 2008 Tungsten carbide Cellulose [57] 2008 Stainless steel powder with benzylamine (mixed mode) Cellulose [58] 2008 Zirconia-silica Agarose [59] 2009 Zirconium dioxide Polyglycidyl methacrylate...System requirements
File format: ePUB
Copy protection: Adobe-DRM (Digital Rights Management)
System requirements:
- Computer (Windows; MacOS X; Linux): Install the free reader Adobe Digital Editions prior to download (see eBook Help).
- Tablet/smartphone (Android; iOS): Install the free app Adobe Digital Editions or the app PocketBook before downloading (see eBook Help).
- E-reader: Bookeen, Kobo, Pocketbook, Sony, Tolino and many more (not Kindle).
The file format ePub works well for novels and non-fiction books – i.e., „flowing” text without complex layout. On an e-reader or smartphone, line and page breaks automatically adjust to fit the small displays.
This eBook uses Adobe-DRM, a „hard” copy protection. If the necessary requirements are not met, unfortunately you will not be able to open the eBook. You will therefore need to prepare your reading hardware before downloading.
Please note: We strongly recommend that you authorise using your personal Adobe ID after installation of any reading software.
For more information, see our ebook Help page.